Valera eyes 2007 US 510(k) filing for biodegradable ureteral stent, studies start in animals
This article was originally published in Clinica
Executive Summary
Valera Pharmaceuticals has begun an animal study of its biodegradable ureteral stent, a device designed to be voided naturally from the body through urine, potentially representing a major advance over existing plastic and metallic ureteral stents, the company claims.